Profile of Viral Hepatitis in Saudi Arabia

Authors: A. A. Alshabanat, R. B. Albacker, A. A. Basalama, A. A. Bin Salamah, A. S. Alfrayh

Abstract:

The study was conducted to investigate the profile of hepatitis in Kingdom of Saudi Arabia, and to determine which age group hepatitis viruses most commonly infect. The epidemiology of viral hepatitis in Saudi Arabia has undergone major changes, concurrent with major socioeconomic developments over the last two to three decades. This disease represents a major public health problem in Saudi Arabia resulting in the need for considerable healthcare resources. A retrospective cross sectional analysis of the reported cases of viral hepatitis was conducted based on the reports of The Ministry of Health in Saudi Arabia about Hepatitis A, B and C infections in all regions from the period of January 2006 to December 2010. The study demonstrated that incidence of viral Hepatitis is decreasing, except for Hepatitis B that showed minimal increase. Of hepatitis A, B, and C, Hepatitis B virus (HBV) was the most predominant type, accounting for (53%) of the cases, followed by Hepatitis C virus (HCV) (30%) and HAV (17%). HAV infection predominates in children (5–14 years) with 60% of viral hepatitis cases, HBV in young adults (15–44 years) with 69% of viral hepatitis cases, and HCV in older adults (>45 years) with 59% of viral hepatitis cases. Despite significant changes in the prevalence of viral hepatitis A, B and C, it remains a major public health problem in Saudi Arabia; however, it showed a significant decline in the last two decades that could be attributed to the vaccination programs and the improved health facilities. Further researches are needed to identify the risk factors making a specific age group or a specific region in Saudi Arabia targeted for a specific type of hepatitis viruses.

Keywords: Epidemiology, Hepatitis, Saudi Arabia.

Digital Object Identifier (DOI): doi.org/10.5281/zenodo.1094425

References:

[1] World Health Organization. Hepatitis B, C and A. World Health Organization Fact Sheet no. 204, 164 and 328 (Revised July 2012).
[2] World Health Organization.Hepatitis C. World Health Organization Fact Sheet no. 164 (Revised July 2012).
[3] World Health Organization.Hepatitis A. World Health Organization Fact Sheet no. 328 (Revised July 2012).
[4] World Health Organization.Hepatitis B Vaccines.WHO Web site. 2003.
[5] Perz JF. The contributions of hepatitis B virus and hepatitis C virus infections to cirrhosis and primary liver cancer worldwide. Journal of Hepatology, 2006, 45: 529-38. Epub 2006 Jun 23.
[6] The world health organization.Sixty third-world health assembly 25March 2010.
[7] Regional Committee for the Eastern Mediterranean(56th session), 5 October 2009.
[8] Al Sebayel M, Khalaf H, Al Sofayan M, Al Saghier M, Abdo A, Al Bahili H. Experience with 122 consecutiveliver transplant procedures at King Faisal Specialist Hospital and Research Center. Ann Saudi Med 2007; 27: 333-338.
[9] Ayoola EA, Gadour MO. Hepatocellular carcinoma in Saudi Arabia: role of hepatitis B and C infection. J GastroenterolHepatology 2004; 19: 665-669.
[10] Mansoor I. Experience of liver disease at a University Hospital in Western Saudi Arabia. Saudi Med J 2002; 23: 1070-1073.
[11] Al Rashed R. Prevalence of hepatitis A virus among Saudi Arabian children: A community based study. Annals of Saudi Medicine 1997; 17 (2): 200-203.
[12] Khalil M, Al Mazrou Y, Al Jeffri M, Al Howasi M. Childhood Epidemiology of hepatitis A virus in Riyadh, Saudi Arabia. Annals of Saudi Medicine, Vol 18, No 1, 1998; 18(1): 18-21.
[13] Ministry of Health statistics Book,http://www.moh.gov.sa/en/Ministry/Statistics/Book/Pages/default.aspx; 1427-1431.